ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,328Medicare Part D Prescriptions Filled, Including Refills

Rank: 79 out of 1006

$591K Total Retail Price of All Prescriptions

Rank: 163 out of 1006

524 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
70% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 524 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

10% of this provider’s 524 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 9,608 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
LISINOPRIL 580 482 1 3
LEVOTHYROXINE SODIUM 496 411 2 2
LOVASTATIN 359 246 3 44
WARFARIN SODIUM 337 324 4 8
FUROSEMIDE 323 261 5 6
OMEPRAZOLE 319 293 6 9
METOPROLOL TARTRATE 257 244 7 7
SIMVASTATIN 250 222 8 1
METOPROLOL SUCCINATE 212 141 9 12
AMLODIPINE BESYLATE 211 184 10 4
POTASSIUM CHLORIDE 211 195 10 30
HYDROCHLOROTHIAZIDE 207 168 12 11
METFORMIN HCL 188 169 13 10
CITALOPRAM HBR 184 172 14 24
DONEPEZIL HCL 181 176 15 17
ATENOLOL 176 167 16 13
ESCITALOPRAM OXALATE 168 154 17 27
DIOVAN 167 166 18 16
TRAZODONE HCL 162 142 19 21
ATORVASTATIN CALCIUM 161 131 20 5
PREDNISONE 160 139 21 33
PANTOPRAZOLE SODIUM 154 143 22 32
NAMENDA 143 134 23 34
LOSARTAN POTASSIUM 139 135 24 22
GABAPENTIN 128 76 25 20
CYMBALTA 113 99 26 41
CARVEDILOL 102 78 27 36
MIRTAZAPINE 101 101 28 26
SERTRALINE HCL 101 73 28 19
PRAVASTATIN SODIUM 97 67 30 15
DILTIAZEM 24HR CD 94 92 31 88
ZOLPIDEM TARTRATE 90 65 32 14
DIGOXIN 89 88 33 52
HYDROCODONE-ACETAMINOPHEN 88 83 S3 34 25
LIDODERM 83 64 35 66
GEMFIBROZIL 82 50 36 159
KLOR-CON M20 80 74 37 70
RISPERIDONE 77 77 38 40
LEVEMIR 76 67 39 195
ADVAIR DISKUS 74 51 40 37
CLOPIDOGREL 68 62 41 46
OLANZAPINE 65 45 42 68
TAMSULOSIN HCL 65 64 42 23
FINASTERIDE 63 62 44 76
ALLOPURINOL 62 51 45 31
QUETIAPINE FUMARATE 61 48 46 45
GLIPIZIDE 60 60 47 69
ALENDRONATE SODIUM 60 56 47 29
ZETIA 55 55 49 51
FENTANYL 54 43 S2 50 74
OXYCODONE-ACETAMINOPHEN 52 34 S2 51 57
ISOSORBIDE MONONITRATE ER 51 38 52 59
TRAMADOL HCL 51 49 52 35
OXYBUTYNIN CHLORIDE ER 51 51 52 92
GLYBURIDE 51 42 R 52 65
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.